Theocharis Stamos, Margeli Alexandra, Vielh Philippe, Kouraklis Gregory
Department of Forensic Medicine and Toxicology, Medical School, University of Athens, 75, Mikras Asias Street, GR 11527 Athens, Greece.
Cancer Treat Rev. 2004 Oct;30(6):545-54. doi: 10.1016/j.ctrv.2004.04.004.
The peroxisome proliferator-activated receptors (PPARs) are nuclear hormone receptors, initially described as molecular targets for compounds which induce peroxisomal proliferation. PPAR-gamma, the best characterized of the PPARs, is a ligand-activated transcription factor and a key regulator of adipogenic differentiation and glucose homeostasis. PPAR-gamma ligands have recently been demonstrated to affect proliferation, differentiation and apoptosis of different cell types. Recent in vitro and in vivo studies suggest the importance of specific PPAR-gamma ligands as cell-cycle modulators, establishing their antineoplastic properties. In this review, the latest knowledge on the role of PPAR-gamma ligands as cell-cycle modulators is presented, discussing also their role in cell proliferation, apoptosis and cancer.
过氧化物酶体增殖物激活受体(PPARs)是核激素受体,最初被描述为诱导过氧化物酶体增殖的化合物的分子靶点。PPAR-γ是PPARs中特征最明确的一种,是一种配体激活的转录因子,也是脂肪生成分化和葡萄糖稳态的关键调节因子。最近已证明PPAR-γ配体可影响不同细胞类型的增殖、分化和凋亡。近期的体外和体内研究表明,特定的PPAR-γ配体作为细胞周期调节剂具有重要作用,证实了它们的抗肿瘤特性。在本综述中,介绍了关于PPAR-γ配体作为细胞周期调节剂作用的最新知识,同时也讨论了它们在细胞增殖、凋亡和癌症中的作用。